Punatinib
【Product name】ICLUSIG
[English common name]Ponatinib
[Chinese common name]Punatinib
[English name]
[Chinese other name]
[indications]Puntanib Iclusig is a kinase inhibitor suitable for the treatment of chronic or accelerated phase, or parental phase, for the treatment of resistance or inability to treat previous tyrosine kinase inhibitors.Chronic myelogenous leukemia (CML)Adult patients or Philadelphia chromosomes that are resistant or intolerant to previous tyrosine kinase inhibitor treatmentsAcute lymphoblastic leukemia (Ph+ALL). This indication is based on the response rate. No trials with Iclusig have been shown to improve disease-related symptoms or increase survival.
【Dosage】45 mg with or without food orally once a day.
[Storage]Store Iclusig tablets at 20° to 25°C (68° to 77°F); Allows an offset of 15° to 30°C (59° to 86°F).Stay away from children.
[Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.